B

beato

browser_icon
Company Domain www.beatoapp.com link_icon
lightning_bolt Market Research

BeatO Company Profile



Background



Overview

BeatO is India's largest virtual diabetes care platform, offering comprehensive and clinically proven programs to prevent, control, and achieve remission of diabetes. Founded in 2015, the company leverages innovative technology and the expertise of diabetologists and certified diet coaches to make diabetes management easier, effective, affordable, and accessible.

Mission and Vision

  • Mission: To make the management of chronic conditions easy, accessible, and affordable for everyone.

  • Vision: To become a globally recognized name in chronic condition management systems for people around the world.


Primary Area of Focus

BeatO specializes in diabetes management, providing a digital health ecosystem that empowers users to monitor and control their blood glucose levels through a combination of technology and expert guidance.

Industry Significance

As a leader in digital diabetes care, BeatO addresses the growing need for accessible and affordable chronic disease management solutions, particularly in a country with a high prevalence of diabetes. Its innovative approach has garnered recognition, including the National Startup Award by the Government of India for its services in the healthcare sector.

Key Strategic Focus



Core Objectives

  • To provide end-to-end diabetes care solutions that are accessible and affordable.

  • To leverage technology and expert guidance to improve health outcomes for individuals with diabetes.


Specific Areas of Specialization

  • Blood glucose monitoring through smartphone-connected glucometers.

  • Personalized care insights and 24/7 access to medical experts, including doctors, health coaches, and nutritionists.

  • Comprehensive diabetes care programs that encompass diet, exercise, and medication management.


Key Technologies Utilized

  • Smartphone-connected glucometers for real-time blood glucose monitoring.

  • Mobile application platform for user engagement and data tracking.

  • Artificial intelligence to provide actionable health insights.


Primary Markets Targeted

  • Individuals with diabetes seeking comprehensive and accessible management solutions.

  • Healthcare providers and institutions aiming to integrate digital health solutions into chronic disease management.


Financials and Funding



Funding History

  • Total Funds Raised: Approximately $47 million.

  • Recent Funding Rounds:

  • Series B: Raised INR 2.69 billion (approximately $33 million) on November 16, 2022, led by a consortium of investors including Blume Ventures, Leo Capital, Orios Venture Partners, Flipkart Ventures, HealthQuad, W Health Ventures, and World Within Ventures.

  • Debt Financing: Raised INR 180 million (approximately $2.4 million) on September 10, 2022.

  • Debt Financing: Raised INR 270 million (approximately $3.2 million) on April 27, 2022.


Intended Utilization of Capital

The funds are primarily intended to enhance product development, expand user acquisition, and strengthen the company's technological infrastructure to support its growing user base and service offerings.

Pipeline Development



Key Pipeline Candidates

BeatO's primary focus is on the continuous development and enhancement of its digital health platform, which includes:

  • Smartphone-Connected Glucometers: Devices that enable users to monitor their blood glucose levels in real-time.

  • Mobile Application: An app that provides personalized care insights, connects users with medical experts, and offers a marketplace for health-related products and services.


Stages of Development

  • Product Development: Ongoing enhancement of the mobile application and integration with health monitoring devices.

  • Market Expansion: Broadening the user base and partnerships with healthcare providers.


Target Conditions

  • Type 1 and Type 2 Diabetes

  • Hypertension


Anticipated Milestones

  • Launch of new features in the mobile application.

  • Expansion into new geographic markets.

  • Partnerships with additional healthcare institutions.


Technological Platform and Innovation



Proprietary Technologies

  • Smartphone-Connected Glucometers: Devices that sync with the BeatO app to provide real-time blood glucose monitoring.

  • Mobile Application Platform: An integrated platform offering personalized care insights, expert consultations, and a marketplace for health-related products.


Significant Scientific Methods

  • Data Analytics: Utilizing user data to provide actionable health insights and personalized care plans.

  • Telemedicine: Enabling remote consultations with healthcare professionals through the mobile app.


Leadership Team



Key Executives

  • Gautam Chopra: Co-Founder and Chief Executive Officer.

  • Yash Sehgal: Co-Founder and Chief Operating Officer.

  • Kunal Kinalekar: Co-Founder and Chief Technology Officer.

  • Navneet Agrawal: Chief Clinical Officer.

  • Siddharth Sehgal: Chief Financial Officer.


Professional Backgrounds and Contributions

  • Gautam Chopra: With a background in technology and healthcare, Gautam co-founded BeatO to address the challenges of diabetes management through digital solutions.

  • Yash Sehgal: Yash brings expertise in operations and strategy, playing a pivotal role in scaling BeatO's services and operations.

  • Kunal Kinalekar: Kunal leads the technological development of BeatO, ensuring the platform's innovation and user-centric design.

  • Navneet Agrawal: As Chief Clinical Officer, Navneet oversees the clinical aspects of BeatO's services, ensuring evidence-based practices.

  • Siddharth Sehgal: Siddharth manages the financial strategy and operations, supporting BeatO's growth and sustainability.


Competitor Profile



Market Insights and Dynamics

The digital health market, particularly in chronic disease management, is experiencing significant growth due to increasing health awareness and the adoption of telemedicine. BeatO operates in a competitive landscape with several key players offering similar services.

Competitor Analysis

  • Wellthy: A health management platform focusing on chronic disease management, including diabetes.

  • Omada Health: Offers digital programs for chronic disease prevention and management.

  • Livongo: Provides a platform for chronic condition management, including diabetes.


Strategic Collaborations and Partnerships

BeatO has established several partnerships to enhance its service offerings:

  • Collaborated to launch a Certificate in Diabetes Education course.

  • Partnered to offer diabetes education programs.

  • Joined forces to provide educational resources on diabetes management.


Operational Insights

BeatO differentiates itself through its comprehensive digital ecosystem, integrating health monitoring devices, expert consultations, and a marketplace for health-related products, providing a holistic approach to diabetes management.

Strategic Opportunities and Future Directions

BeatO aims to expand its user base, enhance its technological infrastructure, and form additional partnerships with healthcare providers to strengthen its market position and continue to innovate in chronic disease management.

Contact Information



  • Website: beatoapp.com

  • Social Media:

  • LinkedIn: BeatO

  • Facebook: BeatO

  • Twitter: @BeatOApp

Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI